Matrixyl vs Palmitoyl Hexapeptide-12
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Palmitoyl Pentapeptide-4, Pal-KTTKS
Matrixyl is the trade name (Sederma) for palmitoyl pentapeptide-4, also written Pal-KTTKS, a collagen-fragment peptide attached to a fatty acid so it can cross skin. Unlike Botox-mimic peptides, it does not touch muscle: it signals skin cells to rebuild collagen, so it is aimed at fine lines, firmness and skin texture rather than expression wrinkles. It is a cosmetic ingredient with one of the better-documented topical studies in the peptide space, though far short of drug-grade proof.
Also: Biopeptide EL, Pal-VGVAPG
Palmitoyl hexapeptide-12 is the six-amino-acid sequence VGVAPG, a repeating piece of elastin, with a fatty acid tail attached so it can get into skin. It is sold under the trade name Biopeptide EL and pitched for firmness and elasticity, the bounce-back that fades with age. It is a cosmetic ingredient, not an FDA-approved drug, and nobody has published an independent clinical trial showing it visibly changes skin.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Matrixyl | Palmitoyl Hexapeptide-12 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | KTTKS is a five-amino-acid piece of type I collagen. When collagen breaks down, fragments like this are released, and the skin reads them as a signal that the matrix needs repair, which prompts fibroblasts to make more collagen and other support proteins, a process called matrikine signaling. Matrixyl essentially feeds the skin that repair signal on purpose. The palmitoyl (fatty acid) tail is bolted on to make the otherwise water-loving peptide lipophilic enough to penetrate the outer skin layer, which is the part that actually lets a topical work. | VGVAPG repeats many times in elastin, the protein that lets skin snap back. When elastin breaks down, fragments like this are released, and back in 1984 researchers showed VGVAPG attracts fibroblasts and monocytes in the lab, which is the basis for calling it a matrikine: a matrix fragment that tells repair cells to show up and get to work. The palmitoyl tail makes the peptide fat-friendly enough to cross the outer skin layer. A 2025 ex vivo study added a twist: on human skin samples the peptide reached the epidermis, used the skin's own calcium to form a gel, and helped dried-out, lipid-stripped skin hold water and stay less stiff. That reads more like a barrier and film effect than proof of new elastin being built. |
| Common Dosing | Limited community data available See research protocols | About 4% of the ingredient solution in a finished product Once or twice daily |
| Administration | Topical (serums, creams) | Topical (serums, creams) |
| Typical Duration | 8-12 weeks for visible results, ongoing use | Manufacturer study ran one month; ongoing use for any maintained effect |
| Best Time to Take | Morning or as directed | Morning and/or evening skincare routine |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Matrixyl has the kind of human data most cosmetic peptides lack. The pivotal Robinson 2005 study in the International Journal of Cosmetic Science was a 12-week, double-blind, placebo-controlled, split-face trial in 93 women aged 35 to 55, comparing a moisturizer with 3 ppm Pal-KTTKS against the same moisturizer alone, and it found significant reductions in wrinkles and fine lines on the peptide side, with good tolerability. Cell and lab studies support the mechanism, showing increased synthesis of collagen I and IV and fibronectin. The frequently quoted figures like 117 percent collagen increase or 68 percent wrinkle reduction come largely from manufacturer in vitro and formulation data, so treat the exact percentages skeptically even though the direction of effect is real. Overall this is a well-tolerated peptide with genuine, if modest, controlled human evidence for texture and fine lines, and it does not require injection. It will not erase deep dynamic wrinkles the way muscle-targeting treatments aim to. | The best peer-reviewed work is a 2025 paper in ACS Applied Bio Materials (Ligorio and colleagues, with co-authors from Estee Lauder) that tracked the peptide in full-thickness human skin from a single donor. It showed penetration into the stratum corneum and epidermis, gel formation driven by calcium, reduced water loss and drying stress in delipidated skin (roughly comparable to 5 percent glycerol for drying stress), and stronger gels when mixed with collagen. Useful mechanistic data, but small samples and no living people. The appearance claims come from the manufacturer: a one-month, double-blind study in 10 women using 4 percent Biopeptide EL twice daily reported 33 percent better firmness and 20 percent better tone. That study is not in PubMed and is far too small to lean on. A separate 2023 trial of an elastin-like recombinant polypeptide built on the same VGVAPG repeat found improved elasticity after 28 days in 30 women, but that was a different molecule. Honest read: plausible biology, real skin penetration, no independent proof of visible results. |
Frequently Asked Questions: Matrixyl vs Palmitoyl Hexapeptide-12
What is the difference between Matrixyl and Palmitoyl Hexapeptide-12?
Matrixyl is a skin & hair peptide that matrixyl is the trade name (sederma) for palmitoyl pentapeptide-4, also written pal-kttks, a collagen-fragment peptide attached to a fatty acid so it can cross skin. unlike botox-mimic peptides, it does not touch muscle: it signals skin cells to rebuild collagen, so it is aimed at fine lines, firmness and skin texture rather than expression wrinkles. it is a cosmetic ingredient with one of the better-documented topical studies in the peptide space, though far short of drug-grade proof. Palmitoyl Hexapeptide-12 is a skin & hair peptide that palmitoyl hexapeptide-12 is the six-amino-acid sequence vgvapg, a repeating piece of elastin, with a fatty acid tail attached so it can get into skin. it is sold under the trade name biopeptide el and pitched for firmness and elasticity, the bounce-back that fades with age. it is a cosmetic ingredient, not an fda-approved drug, and nobody has published an independent clinical trial showing it visibly changes skin. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Matrixyl or Palmitoyl Hexapeptide-12?
Neither is universally "better" - the choice depends on your specific goals. Matrixyl is typically used for skin & hair purposes, while Palmitoyl Hexapeptide-12 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Matrixyl and Palmitoyl Hexapeptide-12 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Matrixyl and Palmitoyl Hexapeptide-12 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.